Tag: AstraZeneca

AI

AI fast-forwards molecular simulations by 10,000-fold

0
A new AI model has become so good at predicting how molecules evolve over time that, in the future, it could speed up the...
AstraZeneca

AstraZeneca Pharma India gets nod to import cancer drug

0
AstraZeneca Pharma India said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import, sell, and distribute Durvalumab (Imfinzi), medicine...
Nyctea

Nyctea Technologies brings electrified purification to drug development

0
Swedish deeptech and medtech startup Nyctea Technologies is gearing up toward market expansion with its patented biomolecular purification technology. A spinout from Chalmers University and backed...
Opioid

Opioid addiction – AstraZeneca’s AZD4041 failure

0
Opioid use disorder (OUD) is a chronic neurological disorder characterized by the compulsive, repeated use of opioid drugs, leading to prolonged self-administration. AstraZeneca recently...
Covishield

After Covishield, Covaxin under the radar

0
A study conducted by researchers at Banaras Hindu University (BHU) says a third of the surveyed individuals who received Bharat Biotech’s Covid-19 vaccine Covaxin...
AstraZeneca

AstraZeneca withdraws Covid vaccine, cites surplus availability

0
AstraZeneca has begun the global withdrawal of its Covid-19 vaccine, citing a surplus of available updated vaccines since the pandemic began. The company has...
AstraZeneca

AstraZeneca acknowledges side-effect of Covishield vaccine

0
AstraZeneca's Covid vaccine can lead to a rare blood clotting condition, the pharmaceutical company has admitted to a UK court for the first time...
diabetes

Nod for Hua’s diabetes drug in partnership with Bayer

0
The recent approval of Hua’s first-in-class diabetes drug in China in collaboration with Bayer puts an end to a decade-long wait for molecules with...
AstraZeneca is planning to acquire TeneoTwo to boost blood cancer treatment. Photo: National Cancer Institute on Unsplash

AstraZeneca to acquire TeneoTwo

0
AstraZeneca is all geared up to buy US-based biotech firm, TeneoTwo in a deal valued at around US$1.27 billion. The development aligns with the...
Covid-19 vaccine in India

The political economy of Covid-19 vaccination

0
There are many things that no one has yet thoroughly or scientifically explained about the current pandemic, including why there are fewer infections in...